To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the efficacy of Esketamine in treating people with rare neurological conditions.
Currently, authorised Esketamine products are not licenced specifically intended for treating people with rare neurological conditions. Before new medicines intended to treat a specific condition can be placed onto the United Kingdom market, they must fir...
Esketamine